Chronic Myelomonocytic Leukemia (CMML) with AML Typical Mutations ( NPM1, FLT3 or CEBPA) Identify a High-Risk CMML Group Independent of Molecular-Cpss
Panelsandra Castano-Diez,Ines Zugasti,Xavier Calvo,Felicitas Schulz,Alejandro Avendano Pita,Elvira Mora,Jose Francisco Falantes,Gemma Azaceta,Mariam Ibanez,Tzu Chen,Cristina Notario,Neus Amer Salas,Monica Lopez-Guerra,Carlos Jimenez-Vicente,Daniel Esteban,Francesca Guijarro,Jose Ramon Alamo Moreno,Albert Cortes-Bullich,Daniel Munarriz, Victor Torrecillas-Mayayo,Ana Triguero,Natalia Tovar,Alexandra Martinez-Roca,Beatriz Merchan Munoz,Esther Carcelero,Ulrich Germing,Beate Betz,Maria Rozman,Leonor Arenillas,Lurdes Zamora,Maria Diez-Campelo,Blanca Xicoy,Jordi Esteve,Marina Diaz-Beya Blood advances（2025）
AI 理解论文
溯源树
样例
